INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2025, Number 2

Cardiovasc Metab Sci 2025; 36 (2)

Atherogenic risk profiles and cardiovascular risk assessment in hospitalized patients with type 2 diabetes

Chale-De la Cruz, Alejandro Ernesto; Quiroz-Gomez, Sergio; Landero-Jiménez, Rubén; Guzmán-Priego, Crystell Guadalupe; Jiménez-Sastré, Alejandro

ABSTRACT

Introduction: cardiovascular diseases are the leading cause of morbidity and mortality among individuals with type two diabetes mellitus, affecting adults aged 20 to 79 years. Objective: the study aims to correlate atherogenic risk factors with the duration of diabetes diagnosis to determine the cardiovascular risk of patients in a hospital ward. Material and methods: this observational, correlational, and crosssectional study was conducted at the Center of Medical Specialties of the Instituto de Seguridad Social del Estado de Tabasco from January to June 2024. A representative sample of three hundred forty-three patients was selected from a population of 3,193, using a 95% confidence level and a five percent margin of error. The Framingham cardiovascular risk prediction table was adapted, achieving validation with a Cronbach’s alpha coefficient of 0.770. Results: among the three hundred forty-three patients evaluated, 39 (11.4%) were found to have a high risk of experiencing a cardiovascular event within the next 10 years. A significant positive correlation was found between cardiovascular risk and the duration since the diagnosis of type 2 diabetes, with a p-value of 0.003. Conclusion: the findings confirm that the duration of diabetes is a significant determinant of cardiovascular risk in hospitalized patients.
  FULL TEXT PDF  

Keywords

cardiology atherogenic diabetes mellitus cardiovascular risk




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Case of coil dislodgement in saphenous vein graft coil occlusion in retrograde...
    2025, Vol.36, Núm. 2
  • Diagnostic challenge: cardiac myeloid sarcoma in a patient with acute myeloid...
    2025, Vol.36, Núm. 2
  • Perception among family members and physicians about the recommendation for...
    2025, Vol.36, Núm. 2
  • Metabolic-Adipose-Cardio-Arterial-Renal- Enterohepatic-Neurological connection...
    2025, Vol.36, Núm. 2
  • Atherogenic risk profiles and cardiovascular risk assessment in hospitalized...
    2025, Vol.36, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 36, Num. 2, Abril-Junio 2025. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/